
Opinion|Videos|March 14, 2025
Recent Medical Advancements: Opportunities and Considerations
Author(s)Daniel E. Kremens, MD, JD
An expert discusses the extended form of carbidopa/levodopa (Crexont) for managing OFF episodes, highlighting trial results that show decreased OFF time and increased ON time, as well as the use of subcutaneous loading of medications in Parkinson disease, which was well tolerated with skin issues as the main adverse effects and resulted in increased ON time without worsening dyskinesia.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
2
SKY-0515 Reduces mHTT, Alexion C5 inhibitors Reduces Relapse Rate, Exploring Stem Cell Innovation in PD
3
A Call for Greater Education in Stem Cell Therapies
4
Earlier Pimavanserin Initiation May Alter Psychosis Symptom Trajectory in Parkinson's Disease, Exploratory Analysis Suggests
5













